PIQUR Logo
X
Privacy Statement

As the protection of your personal data is of particular concern to us, we only process your data based on legal provisions (EU GDPR 2016/679, DSG 1992 [SR235.1]). In this Privacy Statement, we inform you about the most important aspects of data processing in connection with our website.
By transferring your personal data to us and by using our website you confirm that you have read and understood this Privacy Statement.

Contacting us
If you use the contact form on our website or if you contact us by e-mail or telephone, we will process the data provided by you for the purpose of handling your inquiry and for potential follow-up questions; we will delete said data no later than three months after your inquiry has been dealt with. Moreover, your data will only be further processed if it is necessary due to statutory retention requirements or if it is necessary for maintaining and/or asserting any legal rights. Data is only disclosed to the extent that is required for the purposes mentioned above; as far as possible, data is only disclosed within our company.

Applications
Applications of any kind (job offers, internships, diploma theses, unsolicited job applications), which we receive by e-mail, including all data of the applicant and attachments, are only processed by the human resources department and the respective specialist department in order to assess if your profile fits one of our advertised job offers and/or if we will offer you a job that fits your profile. We also process your data for the initiation of an employment relationship with you, if applicable. Your data will be deleted no later than three months after the application procedure has been completed. Moreover, your data will only be further processed if it is necessary due to statutory retention requirements or if it is necessary for maintaining and/or asserting any legal rights. Data is only disclosed to the extent that is required for the purposes mentioned above; as far as possible, data is only disclosed within our company.

Cookies
Our website uses so-called cookies. Cookies are small text files which your browser stores on your device. They cause no damage.
We use cookies to provide a user-friendly experience. Some cookies remain stored on your device until you delete them. They will permit us to recognize your browser if you visit our website again.

No cookies will be stored on your device by our websites without your prior agreement. You can agree to the use of cookies by clicking on the button at the top of the website when you are requested to do so.

You can delete cookies from your device yourself at any time. Deleting or deactivating cookies may limit the functionality of our website.

In addition, this website uses Google Analytics, a web analysis service provided by Google Inc. (‘Google’). Google Analytics also uses cookies to allow for an analysis of your use of the website. The information generated by cookies regarding your use of this website is, in general, transferred to and stored on a server in the US owned by Google. Due to the activation of IP anonymization on this website, however, your IP address will first be shortened by Google within member states of the European Union or other states which are party to the Agreement on the European Economic Area. Only in exceptional cases will the full IP address be transferred to a server in the US owned by Google and shortened there. Google will use this information, on behalf of the website operator, to analyze your use of the website, to prepare reports on website activities and to provide further services related to website and internet use to the website operator. The IP address transferred from your browser by Google Analytics will not be merged with other data from Google. You can prevent the storage of cookies through a corresponding setting of your browser software; please note, however, that then you might not be able to use all functions of this website in full.

Further information on terms of use and data protection is available at https://www.google.com/analytics/terms/us.html and at https://support.google.com/analytics/answer/6004245?hl=en.

Please note that Google Analytics is configured on this website in a way to ensure anonymous collection of IP addresses (IP masking). Your IP address is recorded but will be pseudonymized immediately. This allows for broad localization only.

PIQUR newsletter
You can subscribe to mailing list for media releases on our website. In order for you to subscribe, we need your e-mail address and your confirmation that you agree to receive the newsletter.
You can cancel the newsletter subscription at any time, by clicking on the unsubscribe link in the newsletter or by sending us an e-mail to: media@piqur.com. We subsequently delete your data in connection with the newsletter service immediately.

Your rights
The General Data Protection Regulation provides you with rights of access, rectification, erasure, restriction, data portability, withdrawal and objection. If you believe that the processing of your data violates data protection law or if your rights under data protection law have been violated in any other way you can lodge a complaint with the supervisory authority. However, you may also contact us at any time using the contact details which can be found in our website’s ‘Contact’ section.

Data protection officer
You may contact our data protection officer by e-mail: dpo@piqur.com or by mail to the following address: PIQUR Therapeutics AG, Attn. Data protection officer, Hochbergerstrasse 60C, CH-4057 Basel, Switzerland

Date: 25 May 2018

PIQUR Logo
X
Credits

Corporate Design, Web Design, Web Concept and Code:
SchwizerSchlatter GmbH, St.Gallen

Photography:
Till Forrer Photography, Zürich

PIQUR Logo
X
Disclaimer

No warranty and no liability
The material provided in this site is presented solely to improve public access to information about PIQUR Therapeutics AG.
PIQUR Therapeutics AG will make reasonable efforts to include accurate and current information, wherever possible, but makes no warranties or representations, expressed or implied, as to its accuracy or completeness. PIQUR Therapeutics AG will not be liable for any damages, including but not limited to special or consequential damages, that result from the use of, or the inability to use, the material contained in this site.
PIQUR Therapeutics AG may change the content of this site including the terms that govern the use of this site at any time without prior notice but does not assume any responsibility to update the information provided herein.

Forward looking information
Some of the statements on this site are forward looking. Such statements are inherently subject to known and unknown risks and uncertainties, including scientific, business, economic and financial factors and other factors that may cause actual results, performance or achievements of PIQUR Therapeutics AG and affiliates to be materially different from those expected or anticipated in the forward-looking statements.

PIQUR Therapeutics AG has no responsibility to update the forward-looking statements contained in this site to reflect events or circumstances occurring after the date of publication. You must not rely on this information for investment decisions.

Links to third party sites
Links to third party sites are provided for convenience only, and the inclusion of any links does not imply endorsement by PIQUR Therapeutics AG. The linked sites are not under control of PIQUR Therapeutics AG, and PIQUR Therapeutics AG disclaims any liability for all third party information and the use of it.

Restrictions on use and submissions
The contents of this site are owned and controlled by PIQUR Therapeutics AG. No use of any of these may be made without the prior written consent of PIQUR Therapeutics AG. All submissions communicated to PIQUR Therapeutics AG through this site shall be and remain PIQUR Therapeutics AG’s property. PIQUR Therapeutics AG will be entitled to use your submission for any commercial or other purpose whatsoever without paying any compensation to you. PIQUR Therapeutics AG will be under no obligation to treat your submission as confidential nor to respond to it. The pictures displayed on this website are subject to copyrights and may not be downloaded, copied, distributed or otherwise be used without prior permission of PIQUR Therapeutics AG.

Applicable law and jurisdiction
These terms shall be construed, enforced and performed in accordance with the substantive laws of Switzerland, without reference to the principles of conflicts of laws. The place of jurisdiction is Basel, Switzerland. PIQUR Therapeutics AG makes no representation that any information, materials or functions included are appropriate for use in any other jurisdiction. If you access this site you do so on your own initiative and are responsible for compliance with applicable local laws and regulations.

Address
Directions by car
Directions from railway station Basel Bad Bf
Directions from the railway station Basel SBB
How to find us
Show Map
Address

Address:
PIQUR Therapeutics AG
Hochbergerstrasse 60C
CH-4057 Basel
Switzerland
T +41 61 551 20 50
info@piqur.com

X
Directions by car

Highway A2 exit 1, along in direction Stücki/Kleinhüningen, you can drive up the ramp of the big grey building called Stücki Businesspark (next to the COOP gas station) and park right in front of the building or on the parking below.

X
Directions from railway station Basel Bad Bf

Bus no. 36 in direction Kleinhüningen, get off at bus-station «Hochbergerstrasse» (approx. 4 min.), follow driveway Hochbergerstrasse, after 150m on your right hand side you will see a big grey building called Stücki Business Park, go up the ramp and you find the entrance «C»

X
Directions from the railway station Basel SBB

Tram no. 2 in direction Eglisee, get off at tram-station «Basel Badischen Bahnhof» (approx. 10 min.), change and take bus no. 36 in direction Kleinhüningen, bus-stop «Hochbergerstrasse» (approx. 5 min.), follow driveway Hochbergerstrasse, after 150m on your right hand side you will see a big grey building called Stücki Business Park, go up the ramp and you find the entrance «C».

X
How to find us

PIQUR is located close to the centre of Basel on the north bank of the River Rhine, a few minutes from the borders of France and Germany. It is easily accessible by public transport from the two main railway stations and the airport.

The premises of PIQUR Therapeutics AG are located in the Technology Park Basel in the Stücki Business Park.

X
Contact
Mission – Vision
Leadership Team
Board of Directors
Advisory Boards
Careers
Mission – Vision

 

Mission:

PIQUR aims to improve and extend the lives of cancer patients with the aspiration of curing patients with breakthrough medicines.

 

Vision:

PIQUR seeks to build a highly focused and distinctive independent pharmaceutical company pursuing the development and commercialization of therapies to the highest quality standards for the treatment of difficult cancer types with unmet medical needs.

Leadership Team

+
-
Richard T. Laube – Executive Chairman

Richard Laube, Chairman of PIQUR Therapeutics, is a Swiss-American national with 36 years of experience in a wide range of healthcare businesses, while at Procter&Gamble, Roche, Nestlé and lastly as...

Richard Laube, Chairman of PIQUR Therapeutics, is a Swiss-American national with 36 years of experience in a wide range of healthcare businesses, while at Procter&Gamble, Roche, Nestlé and lastly as CEO of Nobel Biocare. He also has a wide range of board experience, including non-executive board member of Logitech, Chairman of Atkins Nutrition, Chairman of Gerber Life Insurance Company and Chairman of Nestlé NSWA venture capital funds.

+
-
Dr. Melanie Rolli – COO & CMO

Melanie Rolli, Chief Operating Officer and Chief Medical Officer, brings more than a decade of industry experience and senior responsibilities in global development, medical affairs and patient safety. She...

Melanie Rolli, Chief Operating Officer and Chief Medical Officer, brings more than a decade of industry experience and senior responsibilities in global development, medical affairs and patient safety. She joins PIQUR from Novartis Pharma, where she held various positions with increasing responsibilities over the last 14 years, most recently as Global Head Medical Safety. Prior to joining Novartis, she worked as a medical doctor at the University Hospital in Mannheim and as a basic researcher in academic settings in Germany and at the Scripps Research Institute, USA.

+
-
Dr. Doriano Fabbro – CSO

Doriano  Fabbro, Chief  Scientific  Officer,  received  his  Ph.D.  in cell  biology  and biochemistry  at  the  University of Basel, where he worked afterwards for 12 years as Group Leader in...

Doriano  Fabbro, Chief  Scientific  Officer,  received  his  Ph.D.  in cell  biology  and biochemistry  at  the  University of Basel, where he worked afterwards for 12 years as Group Leader in Molecular Tumor Biology. In 1991, he joined the Oncology Group of Ciba-Geigy Basel. After the merger of Ciba-Geigy with Sandoz in 1996 he served at Novartis as Head of Kinase Biology until 2012. Doriano has contributed to the discovery and development of various protein kinase inhibitors for the treatment of cancer; e.g. Midostaurin®, Glivec®, Afinitor®, and Tasigna®. Doriano is author in more than 200 publications and numerous patents in the area of protein kinases regulation, structure, screening and drug discovery. He has been honored with the Novartis Oncology President’s Award (2005).

+
-
Martin Gasser – CFO

Martin Gasser is a highly experienced Chief Financial Officer (CFO) with background in international technology firms. In addition, Martin Gasser is engaged as non-executive board member as well as...

Martin Gasser is a highly experienced Chief Financial Officer (CFO) with background in international technology firms. In addition, Martin Gasser is engaged as non-executive board member as well as finance expert for several SMEs. Martin Gasser currently serves as Managing Director of Reichle Holding AG. Prior to that, he held the position of CFO at Reichle & De-Massari Holding AG.

+
-
Christine Wurz – Head Quality Assurance

Starting from a biochemistry background Christine Wurz has more than 40 years of experience in Quality Control, Quality Assurance and Quality Management. She spent over 25 years at F. Hoffmann-La...

Starting from a biochemistry background Christine Wurz has more than 40 years of experience in Quality Control, Quality Assurance and Quality Management. She spent over 25 years at F. Hoffmann-La Roche Basel in the Pharma Division with microbiological / pre-clinical analytics and in the Vitamins Division, where she built up the GLP Test Facility, the ISO QM framework and performed the very first centralized computerized systems validation used in  GLP.  After Roche Vitamins was taken over by DSM she joined Livec  AG , a consulting company as Head of Quality Management and GxP Computerized Systems Validation (CSV), where she worked for several big-, mid-size and small pharmaceutical companies over the globe. In 2010 she moved to Actelion Pharmaceuticals and in June 2017 to Idorsia Pharmaceuticals. As Global IT Quality Manager she implemented Quality Management to guarantee/maintain qualified IT infrastructure and services to host GxP validated systems and supported all GxP business units for CSV.

+
-
Anita Signorell – Head Human Resources

Anita Signorell has more than 20 years of experience in various functions (sales, marketing and HR) in the tourism, consumer good and the last 4 years in the life...

Anita Signorell has more than 20 years of experience in various functions (sales, marketing and HR) in the tourism, consumer good and the last 4 years in the life science industry.

+
-
Tatsuo Satoh – Head BD & Communication

For the past 15 years, Tatsuo Satoh worked in the life science industry in various roles of increasing responsibilities. He has a scientific background in biochemistry and molecular biology,...

For the past 15 years, Tatsuo Satoh worked in the life science industry in various roles of increasing responsibilities. He has a scientific background in biochemistry and molecular biology, with a degree fom the University of Basel and Swiss TPH. His professional experience ranges from basic and preclinical research, information technology to corporate housekeeping and communication.

Board of Directors

+
-
Richard T. Laube, Executive Chairman

Richard Laube, Executive Chairman of PIQUR Therapeutics, is a Swiss-American national with 36 years of experience in a wide range of healthcare businesses, while at Procter&Gamble, Roche, Nestlé and lastly...

Richard Laube, Executive Chairman of PIQUR Therapeutics, is a Swiss-American national with 36 years of experience in a wide range of healthcare businesses, while at Procter&Gamble, Roche, Nestlé and lastly as CEO of Nobel Biocare. He also has a wide range of board experience, including non-executive board member of Logitech, Chairman of Atkins Nutrition, Chairman of Gerber Life Insurance Company and Chairman of Nestlé NSWA venture capital funds.

+
-
Christian Salz, Vice Chairman

Christian Salz is Swiss national with more than 25 years of management experience, most recently as CEO of Indutrade Switzerland, the Swiss subsidiary of the international industrial group Indutrade....

Christian Salz is Swiss national with more than 25 years of management experience, most recently as CEO of Indutrade Switzerland, the Swiss subsidiary of the international industrial group Indutrade. In addition, he serves on the board several small and medium-sized companies.

+
-
Prof. Dr. Bernd Giese

Bernd Giese is Co-Founder and member of the Board of Directors of PIQUR. Bernd co-directed the synthesis and the bioorganic chemistry of the drugs that are substance of PIQUR. Due...

Bernd Giese is Co-Founder and member of the Board of Directors of PIQUR. Bernd co-directed the synthesis and the bioorganic chemistry of the drugs that are substance of PIQUR.
Due to his contribution in synthetic radical chemistry, electron transfer in DNA and peptides, and investigation of cellular signal transduction pathways using chemical compounds, Bernd is recipient of numerous international awards in chemistry including Karl-Winnacker Award 1976, Carl-Duisberg Award 1977, Gottfried-Wilhelm- Leibniz Award 1987, Merck-Schuchardt Award 1988, Tetrahedron Prize for Creativity in Organic Chemistry 2005, Emil Fischer Medal 2006, Norris Award 2009 and Paracelsus Award 2012.

+
-
Dr. Guido Magni

Guido Magni is a member of the Board of Directors of PIQUR. Guido is currently Venture Partner at Versant Ventures. In 1993, he became Therapeutic Area Head CNS at...

Guido Magni is a member of the Board of Directors of PIQUR. Guido is currently Venture Partner at Versant Ventures. In 1993, he became Therapeutic Area Head CNS at Roche Basel, where he was promoted in 1995 to Head of the Medical Science Group in the development department. He has kept this position for 12 years. The Medical Science at Roche was made up of different groups, including all the therapeutic areas, clinical pharmacology, biostatistics, safety risk management and project management for early projects.

During his tenure as head of medical science, Roche registered 15 NCEs/ NBEs. When he left Roche in 2008 he joined Versant Ventures where he works as a partner in the Basel office.

Guido is currently also a member of the Board of Gensight Biologics, Biotie and AM Pharma.

Advisory Boards

Oncology Advisory Board
Prof. Dr. Josep Tabernero

Chairman of the Oncology Advisory Board, is Head of the Medical Oncology Department and Head of the Gastrointestinal Tumors and Phase I Unit at the Vall d’Hebron University Hospital in Barcelona, Spain. Tabernero is actively involved in molecular targeted therapies and related translational research, with a special focus on EGFR family and PI3K-Akt-mTOR pathway inhibitors. He was elected President of the European Society for Medical Oncology (ESMO) for the 2018-2019 period; ESMO is the leading European cancer organization.

Prof. Dr. Hilary Calvert

Member of the Oncology Advisory Board, has a longstanding interest in cancer drug discovery and development and has been closely involved with the development of Carboplatin®, Raltitrexed®, Pemetrexed® and Rucaparib. He is the Director of Anticancer Drug Discovery and Development and Professor of Cancer Therapeutics at University College London Partners and is based at the UCL Cancer Institute where his role is to foster clinical programs of new drug trials in cancer and drug discovery initiatives.

Prof. Dr. Richard Herrmann

Member of the Oncology Advisory Board, Chief Medical Officer of PIQUR Therapeutics until 2015. From 1991 to 2011, he was Head of the Division of Oncology at the University Hospital Basel, Switzerland, as well as Professor of Medicine at the University of Basel. Additional positions included President of SAKK (Swiss Group for Clinical Cancer Research) from 2004 to 2010, President of Oncosuisse, the Swiss Federation Against Cancer, from 2009 to 2012 and Head of the Department of Clinical Research at Basel University Hospital from 2011 to 2013.

Scientific Advisory Board
Prof. Dr. Roger Williams

Chairman of the Scientific Advisory Board, is Professor at University of Cambridge. His research focuses on developing a detailed structural understanding of the network of interacting pathways involved in phospholipid signalling.

Prof. Dr. Andreas Pfaltz

Member of the Scientific Advisory Board, is Professor of Organic Chemistry at the University of Basel. His research focuses on the development of catalytic methods for organic synthesis, with special emphasis on metal-catalyzed asymmetric reactions

Prof. Dr. Michael N. Hall

Member of the Scientific Advisory Board, joined the Biozentrum of the University of Basel in 1987 where he is currently Professor and former Chair of Biochemistry. He is a world leader in the fields of TOR signalling and cell growth control. In 1991, Hall and colleagues discovered TOR (Target of Rapamycin).

Prof. Dr. Victor Snieckus

Member of the Scientific Advisory Board, Professor and Bader Chair Emeritus at Queen’s University Canada, has made fundamental contributions to synthetic aromatic and heteroaromatic chemistry with significant impact on the discovery and development of medicinal and agrochemical agents.

Prof. Dr. David Spiegel

Member of the Scientific Advisory Board, is Associate Professor of Chemistry and Pharmacology at Yale University. His research focus ranges from synthetic reaction development and natural product synthesis to the construction of functional molecules capable of accomplishing specific biological tasks.

Prof. Dr. Marketa Zvelebil

Member of the Scientific Advisory Board, brings 25 years experience of general bioinformatics but especially of protein structural modelling and ligand docking/QSAR. She is team leader and Reader of Cancer Informatics at the Institute of Cancer Research (ICR), London, in the Breakthrough Breast Cancer division.

Business Advisory
Careers

Working at PIQUR Therapeutics

At PIQUR, we understand that the success of the company is a direct result of the commitment and scientific drive of the whole team. At PIQUR Therapeutics, we foster a culture of innovation and are passionate about improving the lives of cancer patients with breakthrough medicines.

Open positions

Currently, there are no vacancies at PIQUR.

For more information, please contact HR at HR@piqur.com.

Our websites uses Google Analytics and cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our privacy statement.
Accept Decline Google Analytics tracking on this website